Kymera Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing protein degradation therapies. The company's proprietary Pegasus platform enables the discovery of small molecule protein degraders that target disease-causing proteins for destruction. Kymera's pipeline includes investigational treatments for immunological diseases, oncology, and other therapeutic areas, utilizing targeted protein degradation as a novel mechanism of action.